As data from the Kovid-19 pandemic continues to decline in France, the arrival of the first-ever Delta variant in India is at risk of resurrecting 80% of the unaffected population in the UK. Reactive vaccine is the solution.
France, which is in danger of recovering from the effects of the Delta variant, is experimenting with a reaction vaccine. In a press release issued on June 21, the High Authority for Health (HAS) indicated that it had recommended the Reactive Vaccine Strategy, saying, “Since it has been tested in the field for several weeks, the Reinforced ‘test – to complete the warning -‘ protect the strategy and the scope of emerging variants. Limit. “
Therefore, the so-called “reactive vaccine” involves vaccinating the entire group of cases (i.e., all persons in sight of the detected case, in their workplace and / or at home) (school / university) within the framework of the “vaccine recommended population”. Finally, ARNMessager vaccines (Pfizer or Modernna) that have demonstrated greater efficacy on this variant are suitable in this strategy.
From the first case
For HAS, in order to reduce the risk of spreading such emerging variants and significantly reduce the rate of secondary infections, a “reactive vaccination strategy” needs to be implemented as soon as possible – as soon as a disease occurs. The first case of the variant is found. Optimal acceptance is also required to vaccinate the relevant population for the success of this vaccine strategy One “. In this regard, an extensive communication campaign should be launched.
It remains now to place logistics around this reactive vaccine (rapid mobilization of all actors for administration of the vaccine in places where the convoy of cases often comes up).